CRL — Charles River Laboratories International Inc.
CRL (Charles River Laboratories International Inc.) stock: $337.97, $16.19B market cap, $200.4M cash, $16.00B EV, $16.79B fully diluted market cap. Data from Fully Diluted's biotech stocks database.
What they do
These statements are based on our current expectations and beliefs and involve a number of risks, uncertainties and assumptions that are difficult to predict. In addition, these statements include the impact of economic and market conditions on us and our clients, the effects of our cost-saving actions, including on an annualized basis, and the steps to optimize returns to shareholders on an effective and timely basis; and our ability to withstand the current market conditions.